person · Reporting owner
van der Meer Mohr Pauline
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Viatris IncVTRS · Entity 3277 | Director | March 03, 2023 | March 06, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Viatris Inc
Report date March 03, 2023 · Filed March 06, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,245 |
Ending reported balance
After 2023-03-04 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2023-03-04 · Exercise / conversion · Acquired 19,608 · Balance 40,151 Row 2 · 2023-03-04 · Tax withholding · Disposed 589 · Balance 39,562 F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the restricted stock units (RSUs) granted on March 4, 2022. Row 3 · 2023-03-04 · Exercise / conversion · Acquired 705 · Balance 40,267 F2: Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Row 4 · 2023-03-04 · Tax withholding · Disposed 22 · Balance 40,245 F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 17,970 |
Reported balance
After 2023-03-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-03-03 · Grant · Acquired 17,970 · Balance 17,970 F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2023-03-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-03-04 · Exercise / conversion · Disposed 19,608 · Balance 0 F5: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2023-03-04 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-03-04 · Exercise / conversion · Disposed 704.8417 · Balance 0 F6: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the restricted stock units (RSUs) granted on March 4, 2022.
F2: Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F3: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2022.
F4: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024.
F5: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023.
F6: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Mylan II B.V.
Report date November 16, 2020 · Filed November 19, 2020
Section 16 reporting ended · disclosed 2020-11-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-11-16 · Disposition to issuer · Disposed 6,265 · Balance 0 F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $36.14 · Expires 2028-06-29 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-11-16 · Disposition to issuer · Disposed 3,446 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4: These options vested on March 2, 2019. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $27.45 · Expires 2029-03-01 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-11-16 · Disposition to issuer · Disposed 4,352 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5: These options vested on March 2, 2020. |
| Non-Employee Director Stock Option - Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $17.48 · Expires 2030-03-02 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-11-16 · Disposition to issuer · Disposed 6,151 · Balance 0 F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6: These options will vest on March 2, 2021. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2020-11-16 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2020-11-16 · Disposition to issuer · Disposed 9,440 · Balance 0 F7: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F8: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax).
F2: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share.
F3: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination.
F4: These options vested on March 2, 2019.
F5: These options vested on March 2, 2020.
F6: These options will vest on March 2, 2021.
F7: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination.
F8: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 704.8417 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007212 · doc4.xml · derivative · entry 7 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 704.8417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. F6 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 4, 2022 and vested on the same schedule as the underlying RSUs. On May 6, 2022, Viatris filed a registration statement on Form S-3 with respect to its Dividend Reinvestment and Share Purchase Plan; amount represents DEUs that subsequently accrued with respect to such RSUs in June 2022, September 2022 and December 2022 in transactions exempt from Section 16 under Rule 16a-11. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 19,608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007212 · doc4.xml · derivative · entry 6 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023. F5 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 4, 2023. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 22 | $11.13 | $244.86 |
DisclosureSEC source: 0000899243-23-007212 · doc4.xml · nonDerivative · entry 4 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,245 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 4, 2022. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 705 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007212 · doc4.xml · nonDerivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,267 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 6 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 589 | $11.13 | $6,555.57 |
DisclosureSEC source: 0000899243-23-007212 · doc4.xml · nonDerivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,562 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the restricted stock units (RSUs) granted on March 4, 2022. Read SEC document |
| March 04, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 19,608 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007212 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 19:00 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 17,970 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007212 · doc4.xml · derivative · entry 5 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,970 Underlying: Common Stock · 17,970 shares Expires not disclosed F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs will vest on March 3, 2024. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 18:00 UTC | Viatris Inc VTRS · Entity 3277 | SaleCommon Stock | 9,440 | $10.58 | $99,912.02 |
DisclosureSEC source: 0000899243-22-029330 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,543 F1 · balance_after: The reporting person's Form 4 filed on March 4, 2022 overreported by nine shares the number of shares of common stock withheld for the tax liability associated with the vesting and settlement of restricted stock units granted on March 2, 2021 and has been corrected here. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 165.5224 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011991 · doc4.xml · derivative · entry 4 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 165.5224 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Represents DEUs that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F3 · derivative.expiration_date: Represents DEUs that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 165.5224 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011991 · doc4.xml · derivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165.5224 Underlying: Common Stock · 165.5224 shares Expires not disclosed F3 · derivative.exercise_price: Represents DEUs that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F3 · derivative.exercise_date: Represents DEUs that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. F3 · derivative.expiration_date: Represents DEUs that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 3 | $10.39 | $31.17 |
DisclosureSEC source: 0000899243-22-011991 · doc4.xml · nonDerivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,974 F2 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 19:01 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 166 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-011991 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,977 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 3 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 04, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 19,608 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009566 · doc4.xml · derivative · entry 7 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,608 Underlying: Common Stock · 19,608 shares Expires not disclosed F6 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. F6 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs will vest on March 4, 2023. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionDividend Equivalent Units · Derivative | 334.4826 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009566 · doc4.xml · derivative · entry 6 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 334.4826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. F5 · derivative.expiration_date: Represents DEUs that accrued with respect to the RSUs previously granted on March 2, 2021 and vested on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009566 · doc4.xml · derivative · entry 5 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,996 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. F4 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris Inc. (Viatris). These RSUs vested in full on March 2, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 6 | $10.48 | $62.88 |
DisclosureSEC source: 0000899243-22-009566 · doc4.xml · nonDerivative · entry 4 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,811 F3 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the dividend equivalent units (DEUs) that accrued with respect to the RSUs previously granted on March 2, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 335 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009566 · doc4.xml · nonDerivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Fractional shares have been rounded up in connection with the settlement described in footnote 5 pursuant to the terms of the RSU award agreement under the Viatris Inc. 2020 Stock Incentive Plan. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Tax withholdingCommon Stock | 219 | $10.48 | $2,295.12 |
DisclosureSEC source: 0000899243-22-009566 · doc4.xml · nonDerivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,482 F1 · shares: Represents withholding of shares of common stock for the tax liability associated with the vesting and settlement of the restricted stock units (RSUs) granted on March 2, 2021. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 20:12 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 13,996 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-009566 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2021 Filed Dec 23, 2021 18:02 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 120.0574 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-049648 · doc4.xml · derivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334.4826 Underlying: Common Stock · 120.0574 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| September 22, 2021 Filed Sep 24, 2021 18:01 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 113.2715 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-037661 · doc4.xml · derivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214.4252 Underlying: Common Stock · 113.2715 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| June 21, 2021 Filed Jun 23, 2021 20:37 UTC | Viatris Inc VTRS · Entity 3277 | GrantDividend Equivalent Units · Derivative | 101.1537 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025596 · doc4.xml · derivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101.1537 Underlying: Common Stock · 101.1537 shares Expires not disclosed F1 · derivative.exercise_price: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.exercise_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. F1 · derivative.expiration_date: Represents dividend equivalent units ("DEUs") that accrued with respect to restricted stock units ("RSUs") previously granted on March 2, 2021 and vest on the same schedule as the underlying RSUs. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionRestricted Stock Units · Derivative | 9,440 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009927 · doc4.xml · derivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021. F2 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. These RSUs vested in full on March 2, 2021. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 13,996 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009927 · doc4.xml · derivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,996 Underlying: Common Stock · 13,996 shares Expires not disclosed F1 · derivative.exercise_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022. F1 · derivative.expiration_date: Each restricted stock unit (RSU) represents the right to receive one share of common stock of Viatris Inc. ("Viatris"). These RSUs will vest on March 2, 2022. Read SEC document |
| March 02, 2021 Filed Mar 4, 2021 18:35 UTC | Viatris Inc VTRS · Entity 3277 | Exercise / conversionCommon Stock | 9,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-009927 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,705 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:14 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerRestricted Stock Units · Derivative | 9,440 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031495 · doc4.xml · derivative · entry 5 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,440 shares Expires not disclosed F7 · security: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F7 · price: Represents restricted stock units ("RSUs") of Mylan that were exchanged on a one-for-one basis for RSUs of Viatris having substantially the same terms in connection with the Combination. F8 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. F8 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:14 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 6,151 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031495 · doc4.xml · derivative · entry 4 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,151 shares Expires 2030-03-02 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F6 · derivative.exercise_date: These options will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:14 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 4,352 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031495 · doc4.xml · derivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,352 shares Expires 2029-03-01 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F5 · derivative.exercise_date: These options vested on March 2, 2020. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:14 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerNon-Employee Director Stock Option - Right to Buy · Derivative | 3,446 | Not disclosed Strike: $36.14 | Not disclosed |
DisclosureSEC source: 0000899243-20-031495 · doc4.xml · derivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,446 shares Expires 2028-06-29 F3 · security: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F3 · price: Represents stock options to acquire Mylan ordinary shares that were exchanged for stock options to acquire Viatris common stock having substantially the same terms in connection with the Combination. F4 · derivative.exercise_date: These options vested on March 2, 2019. Read SEC document |
| November 16, 2020 Filed Nov 19, 2020 00:14 UTC | Mylan II B.V. MYL · Entity 16217 | Disposition to issuerOrdinary Shares | 6,265 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031495 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that (1) Mylan merged with and into Mylan II B.V. with Mylan II B.V. surviving the merger as the legal successor of Mylan and (2) each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents ordinary shares of Mylan that were exchanged on a one-for-one basis for shares of Viatris common stock in connection with the Combination. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:46 UTC | Viatris Inc VTRS · Entity 3277 | GrantRestricted Stock Units · Derivative | 9,440 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000899243-20-031563 · doc4.xml · derivative · entry 5 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,440 Underlying: Common Stock · 9,440 shares Expires not disclosed F7 · security: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F7 · price: Received in exchange for, and having substantially the same terms as, restricted stock units ("RSUs") of Mylan in connection with the Combination. F8 · derivative.exercise_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. F8 · derivative.expiration_date: Each RSU represents the right to receive one share of common stock of Viatris. The RSUs will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:46 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 6,151 | Not disclosed Strike: $17.48 | Not disclosed |
DisclosureSEC source: 0000899243-20-031563 · doc4.xml · derivative · entry 4 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,151 Underlying: Common Stock · 6,151 shares Expires 2030-03-02 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F6 · derivative.exercise_date: These options will vest on March 2, 2021. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:46 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 4,352 | Not disclosed Strike: $27.45 | Not disclosed |
DisclosureSEC source: 0000899243-20-031563 · doc4.xml · derivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,352 Underlying: Common Stock · 4,352 shares Expires 2029-03-01 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F5 · derivative.exercise_date: These options vested on March 2, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:46 UTC | Viatris Inc VTRS · Entity 3277 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 3,446 | Not disclosed Strike: $36.14 | Not disclosed |
DisclosureSEC source: 0000899243-20-031563 · doc4.xml · derivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,446 Underlying: Common Stock · 3,446 shares Expires 2028-06-29 F3 · security: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F3 · price: Received in exchange for, and having substantially the same terms as, stock options to acquire Mylan ordinary shares in connection with the Combination. F4 · derivative.exercise_date: These options vested on March 2, 2019. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 19:46 UTC | Viatris Inc VTRS · Entity 3277 | GrantCommon Stock | 6,265 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-031563 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,265 F1 · security: On November 16, 2020, Mylan N.V. ("Mylan") completed the transaction pursuant to which Mylan combined with Pfizer Inc.'s ("Pfizer") Upjohn business (the "Upjohn Business") in a Reverse Morris Trust transaction (the "Combination") and Upjohn Inc. ("Upjohn") became the parent entity of the combined Upjohn Business and Mylan business and was renamed "Viatris Inc." ("Viatris"). Pursuant to the terms of the Business Combination Agreement (as amended), dated July 29, 2019, by and among Mylan, Pfizer, Upjohn and certain other affiliated entities, Upjohn and Mylan effected the Combination through a series of transactions, including that each holder of Mylan ordinary shares received one share of Viatris common stock for each Mylan ordinary share held by such holder (subject to any required withholding tax). F2 · price: Represents shares of Viatris common stock acquired in connection with the Combination on a one-for-one basis in exchange for ordinary shares of Mylan. On the effective date of the Combination, the closing price of a Mylan ordinary share was $15.85 per share. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:37 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 6,011 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007029 · doc4.xml · derivative · entry 5 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,011 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2020. F4 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2020. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:37 UTC | Mylan II B.V. MYL · Entity 16217 | GrantRestricted Stock Units · Derivative | 9,440 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007029 · doc4.xml · derivative · entry 4 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,440 Underlying: Ordinary Shares · 9,440 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2021. F3 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2021. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:37 UTC | Mylan II B.V. MYL · Entity 16217 | GrantNon-Employee Director Stock Option-Right to Buy · Derivative | 6,151 | $0.00 Strike: $17.48 | $0.00 |
DisclosureSEC source: 0000899243-20-007029 · doc4.xml · derivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,151 Underlying: Ordinary Shares · 6,151 shares Expires 2030-03-02 F2 · derivative.exercise_date: These options will vest in full on March 2, 2021 and expire on March 2, 2030. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:37 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 2,430 | $17.48 | $42,476.40 |
DisclosureSEC source: 0000899243-20-007029 · doc4.xml · nonDerivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,265 F1 · shares: Represents withholding of ordinary shares for the U.K. tax liability associated with the settlement of the restricted stock units (RSUs) granted on March 1, 2019. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:37 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 6,011 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-007029 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2019 Filed Mar 5, 2019 23:27 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionRestricted Stock Units · Derivative | 4,566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006232 · doc4.xml · derivative · entry 5 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,566 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2019. F4 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs vested in full on March 2, 2019. Read SEC document |
| March 02, 2019 Filed Mar 5, 2019 23:27 UTC | Mylan II B.V. MYL · Entity 16217 | Tax withholdingOrdinary Shares | 1,882 | $27.45 | $51,660.90 |
DisclosureSEC source: 0000899243-19-006232 · doc4.xml · nonDerivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,684 F1 · shares: Represents withholding of ordinary shares for the U.K. tax liability associated with the settlement of the restricted stock units (RSUs) granted on June 29, 2018. Read SEC document |
| March 02, 2019 Filed Mar 5, 2019 23:27 UTC | Mylan II B.V. MYL · Entity 16217 | Exercise / conversionOrdinary Shares | 4,566 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006232 · doc4.xml · nonDerivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:27 UTC | Mylan II B.V. MYL · Entity 16217 | GrantRestricted Stock Units · Derivative | 6,011 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-006232 · doc4.xml · derivative · entry 4 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,011 Underlying: Ordinary Shares · 6,011 shares Expires not disclosed F3 · derivative.exercise_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2020. F3 · derivative.expiration_date: Each RSU represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2020. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 23:27 UTC | Mylan II B.V. MYL · Entity 16217 | GrantNon-Employee Director Stock Option-Right to Buy · Derivative | 4,352 | $0.00 Strike: $27.45 | $0.00 |
DisclosureSEC source: 0000899243-19-006232 · doc4.xml · derivative · entry 3 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,352 Underlying: Ordinary Shares · 4,352 shares Expires 2029-03-01 F2 · derivative.exercise_date: These options will vest in full on March 2, 2020 and expire on March 1, 2029. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:42 UTC | Mylan II B.V. MYL · Entity 16217 | GrantRestricted Stock Units · Derivative | 4,566 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-019222 · doc4.xml · derivative · entry 2 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,566 Underlying: Ordinary Shares · 4,566 shares Expires not disclosed F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2019. F2 · derivative.expiration_date: Each restricted stock unit ("RSU") represents the right to receive one ordinary share of Mylan N.V. These RSUs will vest in full on March 2, 2019. Read SEC document |
| June 29, 2018 Filed Jul 3, 2018 20:42 UTC | Mylan II B.V. MYL · Entity 16217 | GrantNon-Employee Director Stock Option - Right to Buy · Derivative | 3,446 | $0.00 Strike: $36.14 | $0.00 |
DisclosureSEC source: 0000899243-18-019222 · doc4.xml · derivative · entry 1 van der Meer Mohr Pauline · CIK 0001743962 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,446 Underlying: Ordinary Shares · 3,446 shares Expires 2028-06-29 F1 · derivative.exercise_date: These options will vest in full on March 2, 2019, and expire on June 29, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.